![Sanofi halts trials of IL-6 drug for Covid-19, India to continue with trial of another drug of similar class - The Economic Times Sanofi halts trials of IL-6 drug for Covid-19, India to continue with trial of another drug of similar class - The Economic Times](https://m.economictimes.com/thumb/msid-76840716,width-1200,height-900,resizemode-4,imgsize-300372/sanofi-reuters.jpg)
Sanofi halts trials of IL-6 drug for Covid-19, India to continue with trial of another drug of similar class - The Economic Times
![Sanofi: French drugmaker Sanofi looks to spin off its consumer business in India - The Economic Times Sanofi: French drugmaker Sanofi looks to spin off its consumer business in India - The Economic Times](https://m.economictimes.com/thumb/msid-99128840,width-1250,height-720,resizemode-4,imgsize-33148/buy-sanofi-india-target-price-rs-9250-sharekhan-by-bnp-paribas.jpg)
Sanofi: French drugmaker Sanofi looks to spin off its consumer business in India - The Economic Times
![Sanofi, tightening its belt in consumer healthcare, offloads more brands to Brazil's Hypera for $190M | Fierce Pharma Sanofi, tightening its belt in consumer healthcare, offloads more brands to Brazil's Hypera for $190M | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1626272302/Sanofi%20%281%29.jpg/Sanofi%20%281%29.jpg?VersionId=3DMFPgu0fr9_sEZLFhn6AA.8djcrq9jJ)
Sanofi, tightening its belt in consumer healthcare, offloads more brands to Brazil's Hypera for $190M | Fierce Pharma
![Sanofi's site modernization spree rolls on with plan to shift 2,000 staffers to new flexible workspace in New Jersey | Fierce Pharma Sanofi's site modernization spree rolls on with plan to shift 2,000 staffers to new flexible workspace in New Jersey | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/SANOFI%20WALL.jpg?VersionId=XHSASL5or428NclLFS1LIcT8HlhNkzz8)